%0 Journal Article
%T Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways
%A Cheolwon Choi
%A Eunbit Kim
%A Javaria Munir
%A Kee-Hyun Nam
%A Min Suk Song
%A Moo-Jun Baek
%A Nguyen Thi Thao Tran
%A Penchatr Diskul Na Ayudthaya
%A Sae Woong Park
%A Seongho Ryu
%A Sujung Song
%A Sung Hyun Kim
%A Trinh Van Ngu
%A Yun-Ui Bae
%J Archive of "Oncogenesis".
%D 2018
%R 10.1038/s41389-018-0094-y
%X a Relative expression level of MUC15 between tumor (25 cases) and their neighboring normal thyroid tissue (27 cases) in thyroid cancer patients. b MUC15 Immunohistochemical (IHC) positivity in the patients was scored from 0 to 3 according to the percentage positivity (grade 0, 0%; grade 1, 1¨C33%; grade 2, 34¨C66%; grade 3, 67¨C100%). c Relative expression level of MUC15 normalized by GAPDH expression level among Nthy-ori-3-1, TPC-1, and FTC-238 cells. Western blots showing the expression level of the MUC15 protein. d Thyroid tumors have enhanced expression of MUC15 in patients according to TCGA database. e Immunostaining of MUC15 in Nthy-ori-3-1, TPC1 and FTC-238 cells, respectivel
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232104/